# Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement

> **NCT03047681** · — · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Implantation Prosnosis and Complications

## Interventions

- **DIAGNOSTIC_TEST:** venous blood withdrawl

## Key facts

- **NCT ID:** NCT03047681
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02
- **Primary completion:** 2017-08-01
- **Final completion:** 2017-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047681, "Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03047681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*